Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
icosapent ethyl (vascepa) (1 trial)
long-chain triglyceride (1 trial)
Carcinoma (Phase 3)
Trials (1 total)
Trial APIs (2 total)